Thursday, 5 March 2015

CardioBuzz: Weight Loss Drug Trial Troubles

(MedPage Today) -- FDA angry over interim data release suggesting CV benefit of naltrexone/bupropion (Contrave). via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)